Frequency of anti-infliximab antibodies: patients with RA in routine care – (May 2013) m1b1o

Rheumatology, Oxford Journals

04/07/2013

Professor Robert Moots and Dr Steven Young (University of Birmingham School of Immunity and...

Professor Robert Moots and Dr Steven Young (University of Birmingham School of Immunity and Infection), discuss the therapeutic role of antibodies given directly to patients and their response to these antibodies. They review a paper by Krentil et al

Dr John Hanly on lupus nephritis +1 año 04:07 Results from the NEIAA Short Report on Ethnicity +1 año 18:43 Prof Raphaèle Seror on smoking status and the risk of incident RA +1 año 04:27 Wolfgang Schmidt on the use of ultrasound in diagnosing and managing giant cell arteritis (GCA) +1 año 05:47 BSR guidelines on axial spondyloarthritis +1 año 06:31 Ver más en APP Comentarios del episodio 1q74h